Goodwin advised TowerBrook on the deal. TowerBrook Capital Partners (“TowerBrook”) announced its acquisition of a majority stake in Envevo, a UK-based provider of EV design and...
TowerBrook’s Stake Acquisition in Envevo
TCR² Therapeutics’ Agreement with Adaptimmune Therapeutics
Goodwin advised TCR² Therapeutics Inc. on the deal while Ropes & Gray represented Adaptimmune Therapeutics plc. TCR² Therapeutics Inc. (NASDAQ: TCRR) announced its definitive agreement with Adaptimmune...